The Relationship between Leptin Levels and Continuous Positive Airway Pressure Treatment: A Cluster Analysis

Area of Science:

• Endocrinology
• Sleep Medicine
• Biomarkers

Background:

• Leptin, an appetite-suppressing hormone from adipose tissue, is implicated in severe obstructive sleep apnea syndrome (OSAS).
• The utility of leptin levels as a biomarker for OSAS and its treatment remains unclear.

Purpose of the Study:

• To investigate the role of leptin levels in obstructive sleep apnea syndrome (OSAS).
• To assess the impact of continuous positive airway pressure (CPAP) treatment on OSAS patients, stratified by leptin levels and clinical features.

Main Methods:

• Hierarchical cluster analysis of polysomnography data from 97 OSAS patients.
• Evaluation of treatment effects after 6 months of CPAP administration.

Main Results:

• Patients were classified into clusters with normal (Clusters 1 & 2) or high (Clusters 3 & 4) leptin levels.
• Excessive daytime sleepiness improved across all clusters post-CPAP treatment.
• Leptin levels significantly decreased in Cluster 3 following CPAP treatment.

Conclusions:

• Leptin's utility as a general biomarker for CPAP treatment in OSAS is uncertain based on conventional apnea-hypopnea index diagnostics.
• Leptin may serve as a helpful biomarker for specific patient clusters, such as obese women, requiring CPAP treatment.